This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Oncodesign Precision Medicine. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Christopher Gaétan Housseman: Innovator in LRRK2 Kinase Inhibitors
Introduction
Christopher Gaétan Housseman is an inventor based in Massy, France. He is known for his work in the field of biochemistry, particularly focusing on LRRK2 kinase inhibitors. His innovative approach aims to contribute to advancements in therapeutic compounds.
Latest Patent Applications
Christopher Gaétan Housseman has submitted a patent application for MACROCYCLIC LRRK2 KINASE INHIBITORS. The compounds of formula (I) described in this application are useful as LRRK2 kinase inhibitors. This application reflects his commitment to developing new solutions in the medical field.
Conclusion
Christopher Gaétan Housseman is an emerging inventor whose work on LRRK2 kinase inhibitors holds promise for future medical advancements. His contributions to the field are noteworthy, and his ongoing research may lead to significant breakthroughs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile